Karnani Vikram — SEC Form 4 filings

SEC reporting owner CIK 1699488. 4 Form 4 filings on record with FilingPulse; latest filed 2026-02-12.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-11-14 to 2026-02-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
COLLEGIUM PHARMACEUTICAL, INC (COLL)President and CEO, Director36
Dyne Therapeutics, Inc. (DYN)Director11

Form 4 filings — Karnani Vikram

FiledFormIssuerReported transactionsSource
2026-02-124COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 79,264 @ $0 · Grant/award (A): 32,531 @ $0 · Tax withholding (F): 11,296 @ $46.75EDGAR
2025-12-234Dyne Therapeutics, Inc. (DYN)Grant/award (A): 59,665 (derivative) @ $0EDGAR
2025-11-144COLLEGIUM PHARMACEUTICAL, INC (COLL)Tax withholding (F): 8,983 @ $47.35EDGAR
2024-11-144COLLEGIUM PHARMACEUTICAL, INC (COLL)Grant/award (A): 105,972 @ $0 · Grant/award (A): 130,344 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1699488 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →